Susquehanna International Group
BHVN

Susquehanna International Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Susquehanna International Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,591
Closed -$5.53M – 14735
2022
Q3 		$5.53M Buy
36,591
+4,596
+14% +$681K ﹤0.01% 3000
2022
Q2 		$4.66M Buy
31,995
+17,851
+126% +$2.28M ﹤0.01% 3306
2022
Q1 		$1.68M Sell
14,144
-37,306
-73% -$4.65M ﹤0.01% 5870
2021
Q4 		$7.09M Buy
51,450
+19,103
+59% +$2.43M ﹤0.01% 3175
2021
Q3 		$4.49M Buy
32,347
+19,078
+144% +$2.38M ﹤0.01% 4154
2021
Q2 		$1.29M Sell
13,269
-59,787
-82% -$4.85M ﹤0.01% 7049
2021
Q1 		$4.99M Sell
73,056
-243,909
-77% -$19.7M ﹤0.01% 3918
2020
Q4 		$27.2M Buy
316,965
+303,400
+2,237% +$25.7M ﹤0.01% 1440
2020
Q3 		$882K Buy
13,565
+9,273
+216% +$608K ﹤0.01% 6426
2020
Q2 		$314K Sell
4,292
-251,450
-98% -$13.4M ﹤0.01% 8284
2020
Q1 		$8.7M Buy
255,742
+85,209
+50% +$3.9M ﹤0.01% 1893
2019
Q4 		$9.28M Sell
170,533
-41,812
-20% -$2.07M ﹤0.01% 2173
2019
Q3 		$8.86M Buy
212,345
+179,952
+556% +$7.6M ﹤0.01% 2113
2019
Q2 		$1.42M Sell
32,393
-193,414
-86% -$10.9M ﹤0.01% 4898
2019
Q1 		$11.6M Buy
225,807
+173,508
+332% +$7.5M ﹤0.01% 1602
2018
Q4 		$1.93M Buy
+52,299
New +$1.89M ﹤0.01% 3572
2018
Q3 		– Sell
-11,510
Closed -$423K – 11012
2018
Q2 		$455K Sell
11,510
-12,262
-52% -$389K ﹤0.01% 6984
2018
Q1 		$612K Sell
23,772
-7,342
-24% -$220K ﹤0.01% 6225
2017
Q4 		$839K Buy
31,114
+23,041
+285% +$634K ﹤0.01% 5595
2017
Q3 		$302K Buy
+8,073
New +$245K ﹤0.01% 7385

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Susquehanna International Group's BHVN Position: Q4 2022 in Review

Susquehanna International Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 36,591 shares — an estimated $5.53M sold.

Susquehanna International Group first reported a position in BHVN in Q3 2017 and held it in 20 quarters. The position peaked at $27.2M in Q4 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Susquehanna International Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 36,591 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $5.53M.
  • Susquehanna International Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 20 quarters.
  • Susquehanna International Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $27.2M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.